Reply to the letter of Griffioen et al. on endoglin/CD 105 as a tumor endothelial treatment target [2]

P. E. Thorpe; F. J. Burrows

doi:10.1007/BF01806192

Reply to the letter of Griffioen et al. on endoglin/CD 105 as a tumor endothelial treatment target [2]

P. E. Thorpe, F. J. Burrows

Pharmacology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	241-242
Number of pages	2
Journal	Breast Cancer Research and Treatment
Volume	39
Issue number	2
DOIs	https://doi.org/10.1007/BF01806192
State	Published - Jan 1 1996

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1007/BF01806192

Cite this

@article{a7698f225d9649ddbaaf5dc88777e8b1,

title = "Reply to the letter of Griffioen et al. on endoglin/CD 105 as a tumor endothelial treatment target [2]",

author = "Thorpe, {P. E.} and Burrows, {F. J.}",

year = "1996",

month = jan,

day = "1",

doi = "10.1007/BF01806192",

language = "English (US)",

volume = "39",

pages = "241--242",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer New York",

number = "2",

}

TY - JOUR

T1 - Reply to the letter of Griffioen et al. on endoglin/CD 105 as a tumor endothelial treatment target [2]

AU - Thorpe, P. E.

AU - Burrows, F. J.

PY - 1996/1/1

Y1 - 1996/1/1

UR - http://www.scopus.com/inward/record.url?scp=0029810069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029810069&partnerID=8YFLogxK

U2 - 10.1007/BF01806192

DO - 10.1007/BF01806192

M3 - Letter

AN - SCOPUS:0029810069

SN - 0167-6806

VL - 39

SP - 241

EP - 242

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 2

ER -

Reply to the letter of Griffioen et al. on endoglin/CD 105 as a tumor endothelial treatment target [2]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this